Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - OTHER CURRENT ASSETS
Other Current Assets ALLO - Allogene Therapeutics, Inc.
10.4 M
LAST VALUE
13.97%
2 YEAR CAGR
13.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR